| Patient | Joe Louis |
|---|---|
| Date of birth | 1914-05-13 |
| Identifiers | MRN HR-BX002-SYN-TD; SSN (made up) 000-02-6639 |
| Document date | 1969-08-10 |
| Author | Desmond Achterberg-Cole, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-week review: psychotic symptoms, urine tests and blood pressure. [S]
Mr. Louis returns four weeks after intake. About five days ago he noticed that he no longer believed he was being followed, and he now calls those fears part of the cocaine. He sleeps six to seven hours. In the first week of aripiprazole he felt a little restless in the evenings, which passed. All six contingency management urine tests have been negative, and he has drawn several prizes. He has had three therapy sessions and is working on what he does in the evenings and when he travels. His cold from the sick visit cleared within a week without a decongestant. His home blood pressure readings over the past week average 144/90. He met the social worker. He has signed a release allowing the clinic to talk with one family member he chose about his plan; no conversation has taken place yet. [S]
| Element | Detail |
|---|---|
| Cocaine | None for four weeks; six of six urine tests negative |
| Psychotic symptoms | Resolved about five days ago; insight full |
| Aripiprazole | Mild evening restlessness in the first week only |
| Home blood pressure | Average 144/90 mmHg over seven days |
| Mood | PHQ-9 4; GAD-7 5 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy better; sleeping six to seven hours |
| Cardiovascular | Negative | No chest pain, palpitations or breathlessness |
| Neurological | Negative | No restlessness now; no tremor |
| Psychiatric | Negative | No persecutory beliefs or hallucinations; no thoughts of suicide or of harming anyone |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with fentanyl test strips and instruction for him and anyone he lives with | One spray as needed for suspected overdose; repeat in 2 to 3 minutes if needed | Nasal route | 1969-07-13 | active | S |
| Aripiprazole 5 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1969-07-20 to 1969-09-21 | completed | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-08-10 | active | S |
| Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestion | Two sprays in each nostril up to every 4 hours as needed | Nasal route | 1969-08-03 to 1969-08-08 | completed | S |
| Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for sore throat or aches, no more than 3,000 mg a day | One or two tablets every 6 hours as needed, no more than 3,000 mg a day | Oral route | 1969-08-03 to 1969-08-08 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1969-08-10 | Body height | 187 | cm | S |
| 1969-08-10 | Body weight | 101.8 | kg | S |
| 1969-08-10 | Body mass index (BMI) [Ratio] | 29.1 | kg/m2 | S |
| 1969-08-10 | Systolic blood pressure | 146 | mm[Hg] | S |
| 1969-08-10 | Diastolic blood pressure | 92 | mm[Hg] | S |
| 1969-08-10 | Heart rate | 82 | /min | S |
| 1969-08-10 | Respiratory rate | 16 | /min | S |
| 1969-08-10 | Body temperature | 36.7 | Cel | S |
| 1969-08-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1969-08-10 | Albumin/Creatinine [Mass Ratio] in Urine | 14 | mg/g{creat} | <=29 mg/g{creat} | Normal | S |
| 1969-08-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1969-08-10 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S |
Vital signs recorded on 1969-08-10; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 146/92, pulse 82; weight 101.8 kg, BMI 29.1 |
| Cardiovascular | Regular rhythm; no murmur; no carotid bruits |
| Neurological | No tremor or rigidity; no akathisia on observation; AIMS 0 |
| Psychiatric | Relaxed, warm and humorous; no delusional content; insight full |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Persecutory thoughts and poor sleep for about two months: a fixed belief that people are following him and plan to harm him, three to four hours of sleep a night, partial insight; cause under evaluation | resolved | confirmed | R41.89 | S — Synthetic presenting problem anchored to his documented fears of a plot against his life; resolved into the diagnosis at the consultation. Not a claim about his real symptoms. |
| Cocaine use disorder, severe (seven of eleven DSM-5-TR criteria): intranasal cocaine most days for about a year, last use three days before intake | resolved | confirmed | F14.20 | S — Synthetic modern coding at intake; superseded at the consultation by the combined code once the psychotic disorder was diagnosed. Person-first language; not a claim about his real diagnosis. |
| Cocaine use disorder, severe, with cocaine-induced psychotic disorder (persecutory delusions during heavy use, persisting ten days after the last use, with no history of psychosis off cocaine, a normal examination and no evidence of a neurocognitive disorder); psychotic symptoms resolved within four weeks on aripiprazole | active | confirmed | F14.250 | S — Synthetic modern diagnosis made at the consultation. Not a claim about his real diagnosis. |
| Raised blood pressure at intake (154/98 mmHg) three days after cocaine use, without a diagnosis of hypertension; home readings planned | resolved | confirmed | R03.0 | S — Synthetic presenting finding; resolved into a diagnosis of hypertension at four weeks. |
| Hypertension, stage 2, confirmed four weeks after the last cocaine use (clinic 146/92, home average 144/90 mmHg), with mild concentric left ventricular hypertrophy and a normal aortic root on echocardiography; treated with amlodipine | active | confirmed | I10 | S — Synthetic modern diagnosis made at the four-week visit. |
| Financial insecurity: years of tax debt from his time as a well-paid athlete, now settled, left him with no savings; irregular income from paid appearances; worry about money keeps him awake | active | confirmed | Z59.86 | S — Synthetic social need anchored to his documented tax debt. |
| Acute viral upper respiratory infection (common cold) for three days; rapid tests negative for influenza and COVID-19; resolved within ten days without antibiotics | resolved | confirmed | J06.9 | S — Synthetic acute illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Self-management | Cocaine use since the last visit (his own account), cravings and triggers | Every visit | Completed today | No cocaine for four weeks; cravings less often |
| Laboratory | Urine drug tests in contingency management, with fentanyl, and prize draws for negative results | Twice weekly for twelve weeks, then at visits | Completed today | Six of six tests negative for cocaine and fentanyl; prizes drawn |
| Examination | Psychotic symptoms, insight and sleep | Every visit | Completed today | No persecutory beliefs for about five days; insight full; sleeping six to seven hours |
| Medication safety | Antipsychotic safety: weight, blood pressure, akathisia (Barnes scale) and abnormal movements (AIMS) | Weight and akathisia at every visit while on treatment; AIMS at baseline and every six months | Completed today | Weight 101.8 kg, up 0.8 kg; mild restlessness in the first week, now gone; no akathisia; AIMS 0 |
| Laboratory | Fasting glucose or hemoglobin A1c and lipids on an antipsychotic | Baseline, at four months, then yearly | Up to date | Baseline done; next at four months if he is still on aripiprazole |
| Examination | Cognitive screen (MoCA) | At baseline and again once he is well and off cocaine | Due | Repeat at the ten-week visit, after a longer time well |
| Examination | Blood pressure in clinic and at home | Every visit; home readings before diagnosis and after each change | Completed today | Clinic 146/92; home average 144/90 mmHg; stage 2 hypertension; amlodipine started |
| Laboratory | Urine albumin-to-creatinine ratio, creatinine and potassium at diagnosis of hypertension | At diagnosis, then yearly | Completed today | Urine albumin-to-creatinine ratio 14 mg/g; creatinine 1.16 mg/dL, eGFR 74 and potassium 4.1 mmol/L at intake |
| Imaging | Echocardiogram for stage 2 hypertension or left ventricular hypertrophy | At diagnosis | Ordered | Booked for the morning of the ten-week visit |
| Survey | Suicide and violence risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or of harming anyone; 988 in his phone |
| Medication safety | Naloxone and fentanyl test strips on hand | Every visit | Completed today | Naloxone and test strips still at home |
| Survey | Depression (PHQ-9) and anxiety (GAD-7) | At baseline and every four weeks while in treatment | Completed today | PHQ-9 4, item 9 scored 0; GAD-7 5 |
| Self-management | Cognitive behavioral therapy | Weekly | Completed today | Three sessions attended |
| Self-management | Finances, social work and taxpayer services | Every visit | Referred | Budget made with the social worker; Low Income Taxpayer Clinic appointment next month |
| Self-management | Family involvement, only with his consent | Every visit | Completed today | He signed a release for one family member he chose; no contact yet |
Goal progress:
Guideline basis: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020); Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026)
Follow-up: Preventive visit in five weeks. Ten-week review in six weeks with the echocardiogram that morning and the MoCA. Home readings daily for two weeks, then twice a week. Next scheduled visit 1969-09-14: periodic adult preventive visit. [S]